StockData
SELLAS Life Sciences Group, Inc. logo

SELLAS Life Sciences Group, Inc. (SLS) stock

SLSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$19.15+11.68 (+156.36%)

Close on Nov 17, 2026Market cap $3.87BP/E –Yield –

SELLAS Life Sciences price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

SELLAS Life Sciences's price to sales ratio was 29.5× on Apr 28, 2023, against 5.7× a year earlier. Over the last 2 years it ranged from 5.7× to 489.6×, with a median of 23.7×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Apr 28, 202329.5×−19.1
2022Dec 30, 202248.6×+39.3
2021Dec 31, 20219.2×−466.3
2015Apr 30, 2015475.6×–

More SELLAS Life Sciences figures

See a number that looks wrong?